RNCOS has recently added a new Market Research Report titled, “Infectious Disease Molecular Diagnostics Outlook 2015” to its report gallery. The molecular diagnostics (MDx) market represents one of the fastest growing segments of global IVD industry. The overall market is estimated to have reached by around US$ 5.4 Billion in 2011 across the globe and is further estimated to grow at a healthy CAGR of around 10% during 2012-2015. Though a very small proportion of government expenditure is imparted for diagnostic care, it influences significant number of medical decisions. There has been a huge increase in the number of technologically advanced molecular diagnostics tests in recent times that led to create a substantial opportunity in the segment. The future landscape will also be impacted by a proliferation in tests volume and active private sector participation.
Infectious diseases account for the leading position in the global MDx market. In 2011, the market contributed around 52% to the revenue patterns attained from the sales of MDx products/technologies. Further dominated by HIV and CT/NG testing, the infectious disease market is anticipated to grow at the CAGR of around 11% during the forecast period, 2012-2015. In this context, our report “Infectious Disease Molecular Diagnostics Outlook 2015”, has effectively monitored the current and future outlook of the infectious disease MDx’s market as a whole and its segments on an individual basis. Our study has also demonstrated the leading position of key methods used in tests for infectious diseases.
There are some of the prominent players in the infectious molecular diagnostics market who are actively participating in industry development. Companies, such as Roche Molecular Diagnostics, bioMerieux, Becton and Dickinson, Abbott Molecular, and Gen-Probe are the leading market players with high-selling platforms and screening tests used for key infectious diseases. Our report provides an in-depth insight on these players in the competitive landscape section. The section covers an effective insight into the businesses of all the companies and its infectious disease-related diagnostic products.
The report, which is spread in around 85 pages, is a comprehensive analysis, covering all the key aspects of the global infectious disease market. It investigates the current market trends that impact the sector in a significant manner. Moreover, a prudent analysis on the performance of sector in key diseases have been also covered that will be a source of complete knowledge and insight for the investors/clients. Overall, the report is an optimum presentation of infectious disease diagnostics sector worldwide, which caters to all those interested in healthcare/diagnostics domain.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM411.htm
Some of our Related Reports are:
- Global API Market Analysis (http://www.rncos.com/Report/IM320.htm)
- Global Telemedicine Market Analysis (http://www.rncos.com/Report/IM331.htm)
- Personalized Medicine Market Analysis (http://www.rncos.com/Report/IM305.htm)
- Global Regenerative Medicine Market (http://www.rncos.com/Report/IM363.htm)
- Emerging Pharmaceutical Markets Globally
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.